Precision Medicine in IBD Clinical Research

Hear what the experts had to say in this recent live stream event with Dr. Séverine Vermeire, Dr. Deanna Nguyen, and Dr. Niels Vande Casteele presenting Precision Medicine in IBD Clinical Research.

Dr. Vermeire presents how a translational medicine program successfully supported the development of a new compound – a gut-selective pan-Janus kinase inhibitor.

Dr. Nguyen presents The Application of Translational Medicine to Support an Early Drug Development Program for a Gut-Selective Compound.

Dr. Vande Casteele discusses driving innovation with method development and validation and the implementation of precision medicine in global clinical trials.

Dr. Vipul Jairath, Vice President, Medical Research and Development, Alimentiv leads a panel discussion on Precision Medicine.

Click “Read More” to view the Live Stream event.